Solutions for Common Challenges in Developing PCR-Based Diagnostic Assays

Molecular diagnostic assays have become increasingly popular during the global COVID-19 pandemic with the need to detect the disease as early as possible to prevent further spread.

While antigen-based tests can effectively detect the presence of pathogens, nucleic acid-based tests offer advantages in early detection and sensitivity. There are different methods used in molecular diagnostic assays, including isothermal amplification for at home point-of-care testing and polymerase chain reaction (PCR) for clinical labs and point-of-care testing sites.

This on-demand webinar explores the common challenges developers and manufacturers encounter when developing PCR tests and how these challenges can be overcome with the right technologies.

Watch this on-demand webinar to learn:

  • The differences and advantages between isothermal and thermocycling molecular diagnostic tests
  • The common challenges associated with developing and manufacturing PCR-based molecular diagnostic assays
  • How to overcome common challenges in developing and manufacturing PCR-based assays with enzyme and master mix technologies

Complete this form to watch this webinar on-demand:

PCR Reagents & Kits for Molecular Diagnostics